See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2012

A Road Map of Cell Therapy Brazil

Presenter: Antonio C. Campos de Carvalho

January 26, 2012

Presentation CTO 2012

Can Left Main Severity Be Assessed Angiographically?

Presenter: Sorin Brener

February 22, 2012

Presentation

Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients

Presenter: Mitsuyasu Terashima

February 29, 2012

Presentation

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Presenter: 53202|Dean Kereiakes

March 28, 2012

Presentation

Transcatheter Aortic Valve Replacement: Outcomes of Pts with Moderate or Severe Mitral Regurgitation

Presenter: S. Toggweiler

April 05, 2012

Presentation

Relationship Between CYP2C19 Polymorphisms and Ischemic and Bleeding Outcomes in Stable Outpatients

Presenter: Deepak L. Bhatt

April 09, 2012

Presentation Fellows 2012

Contrast Nephropathy

Presenter: Giora Weisz

April 20, 2012

Presentation

Outcomes of Discontinuing Rivaroxaban vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation (A-fib)

Presenter: M. Patel

April 25, 2012

Presentation

Intracranial Hemorrhage in A-fib Patients During Anticoagulation with Warfarin or Dabigatran

Presenter: Robert G. Hart

April 27, 2012

Presentation

Activate-SF Registry: Prevalence and Factors Associated with False-Positive STEMI Diagnoses at Primary PCI-Capable Centers

Presenter: James M. McCabe

May 08, 2012

Advertisement

Slides

A Road Map of Cell Therapy Brazil

Can Left Main Severity Be Assessed Angiographically?

Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Transcatheter Aortic Valve Replacement: Outcomes of Pts with Moderate or Severe Mitral Regurgitation

Relationship Between CYP2C19 Polymorphisms and Ischemic and Bleeding Outcomes in Stable Outpatients

Contrast Nephropathy

Outcomes of Discontinuing Rivaroxaban vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation (A-fib)

Intracranial Hemorrhage in A-fib Patients During Anticoagulation with Warfarin or Dabigatran

Activate-SF Registry: Prevalence and Factors Associated with False-Positive STEMI Diagnoses at Primary PCI-Capable Centers

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content